1. Home
  2. MRVI vs NMG Comparison

MRVI vs NMG Comparison

Compare MRVI & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • NMG
  • Stock Information
  • Founded
  • MRVI 2014
  • NMG 2011
  • Country
  • MRVI United States
  • NMG Canada
  • Employees
  • MRVI N/A
  • NMG N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • NMG Other Metals and Minerals
  • Sector
  • MRVI Health Care
  • NMG Basic Materials
  • Exchange
  • MRVI Nasdaq
  • NMG Nasdaq
  • Market Cap
  • MRVI 376.2M
  • NMG 448.1M
  • IPO Year
  • MRVI 2020
  • NMG 2017
  • Fundamental
  • Price
  • MRVI $3.24
  • NMG $2.78
  • Analyst Decision
  • MRVI Hold
  • NMG Strong Buy
  • Analyst Count
  • MRVI 9
  • NMG 3
  • Target Price
  • MRVI $4.54
  • NMG $4.22
  • AVG Volume (30 Days)
  • MRVI 1.7M
  • NMG 1.7M
  • Earning Date
  • MRVI 11-06-2025
  • NMG 11-13-2025
  • Dividend Yield
  • MRVI N/A
  • NMG N/A
  • EPS Growth
  • MRVI N/A
  • NMG N/A
  • EPS
  • MRVI N/A
  • NMG N/A
  • Revenue
  • MRVI $219,830,000.00
  • NMG N/A
  • Revenue This Year
  • MRVI N/A
  • NMG N/A
  • Revenue Next Year
  • MRVI $7.27
  • NMG N/A
  • P/E Ratio
  • MRVI N/A
  • NMG N/A
  • Revenue Growth
  • MRVI N/A
  • NMG N/A
  • 52 Week Low
  • MRVI $1.67
  • NMG $1.22
  • 52 Week High
  • MRVI $8.29
  • NMG $6.06
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 50.18
  • NMG 45.43
  • Support Level
  • MRVI $3.32
  • NMG $2.73
  • Resistance Level
  • MRVI $3.55
  • NMG $6.06
  • Average True Range (ATR)
  • MRVI 0.19
  • NMG 0.71
  • MACD
  • MRVI -0.04
  • NMG -0.15
  • Stochastic Oscillator
  • MRVI 8.82
  • NMG 2.33

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.

Share on Social Networks: